A general view of CD33(+) leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy

Acute myeloblastic leukemia (AML) is the most frequent acute leukemia in adulthood with very poor overall survival rates. In the past few decades, significant progresses had led to the findings of new therapeutic approaches and the better understanding of the molecular complexity of this hematologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathi, Ezzatollah, Farahzadi, Raheleh, Sheervalilou, Roghayeh, Sanaat, Zohreh, Vietor, Ilja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106116/
https://www.ncbi.nlm.nih.gov/pubmed/32269970
http://dx.doi.org/10.5045/br.2020.55.1.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106116/
https://www.ncbi.nlm.nih.gov/pubmed/32269970
http://dx.doi.org/10.5045/br.2020.55.1.10

Ejemplares similares